Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
Eliquis3.57B31.83%
Opdivo2.27B20.22%
Other1.24B11.06%
Revlimid936M8.36%
Orencia770M6.87%
Pomalyst/Imnovid658M5.87%
Yervoy624M5.57%
Reblozyl478M4.27%
Other Growth products403M3.60%
Breyanzi263M2.35%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States34.11B70.61%
International13.2B27.33%
Other996M2.06%